Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086255
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2004-06-29
Brief Title:
Tiagabine for the Treatment of Cocaine Dependence - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Tiagabine for the Treatment of Cocaine Dependence
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess tiagabine for the treatment of cocaine dependence
Detailed Description:
To assess the efficacy and safety of tiagabine in reducing cocaine use in subjects with cocaine dependence It is hypothesized that tiagabine treatment compared to placebo will be associated with fewer days of cocaine use as assessed by self-report confirmed with urine assays for benzoylecgonine BE This is a double-blind placebo-controlled parallel-group design study in which after screening and a 2-week baseline assessment period subjects will be equally randomly assigned to 1 of 2 treatment groups tiagabine or matched placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None